Cite

HARVARD Citation

    Lally, L. et al. (2016). Brief Report: A Prospective Open‐Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica. Arthritis & rheumatology. 68 (10), pp. 2550-2554. [Online]. 
  
Back to record